Last updated: August 13, 2025
Introduction
Patent KR20080019297, filed in South Korea, pertains to innovative pharmaceutical compositions or methods, aiming to secure intellectual property rights for a novel drug entity or therapeutic method. Analyzing this patent’s scope and claims provides critical insights into its competitive positioning, patent protection breadth, and potential influence on the South Korean and global drug patent landscape.
Patent Overview and Filing Context
The patent KR20080019297 was filed on February 12, 2008, published on August 14, 2009, by the Korea Intellectual Property Office (KIPO). It involves a novel pharmaceutical composition or method—specific details are crucial for understanding the enforcement scope, inventive specifics, and potential market segment.
Given the publication timeline and filing date, the patent plays a role in the early 2000s wave of compound-specific and method-of-use innovations within South Korea’s burgeoning biopharmaceutical sector. It may cover active compounds, delivery mechanisms, or treatment protocols relevant for therapeutic areas such as oncology, infectious disease, or metabolic disorders.
Scope of the Patent
1. Technical Focus
While complete claims are necessary for precise scope determination, typically, such patents encompass:
- Novel chemical entities or derivatives with specific pharmacological activity.
- Pharmaceutical compositions comprising these compounds, potentially combined with excipients or carriers.
- Specific methods of treatment for targeted diseases or conditions, often utilizing the claimed compounds or compositions.
2. Limitations and Breadth
- If the patent claims cover a specific chemical structure, the broadness is limited to derivatives with similar functional groups.
- Claims directed at methods of preparing the compound or methods of administering it expand the patent’s scope to manufacturing and use.
- Combination claims with other drugs could extend scope but also risk added prior art considerations.
3. Claim Types
Patent KR20080019297 likely contains multiple claim types:
- Independent Claims: Covering the core compound or method.
- Dependent Claims: Detailing specific embodiments, such as dosage forms, concentration ranges, or therapeutic indications.
4. Language and Claim Construction
The language of the claims determines enforceability:
- Exact chemical structure definitions or patent library identifiers (e.g., CAS numbers).
- Use of functional language (e.g., "effective amount," "therapeutically effective") broadens scope but can invite interpretation challenges.
Claims Analysis
While the complete set of claims is needed for absolute accuracy, typical analysis includes:
1. Core Claim(s)
- I.e., a chemical compound with a specific structure that exhibits a defined pharmacological activity.
- For example, a compound with a particular substitution pattern in a heterocyclic ring conferring anticancer activity.
2. Method Claims
- E.g., a method of treating a disease using the compound, specifying route, dosage, or frequency.
3. Composition Claims
- Pharmaceutical formulation claims involving the compound plus carriers, stabilizers, or adjuvants.
4. Use Claims
- Method of use claims claiming the application of the compound for specific medical conditions.
5. Scope Considerations
- Patent claims' breadth influences potential invalidity or non-infringement: narrower claims may ease litigation but limit exclusivity; broader claims increase risk of prior art invalidation but provide wider protection.
Patent Landscape in South Korea
1. Regional Patent Environment
South Korea’s patent regime is robust, with KIPO adapting to international standards, emphasizing inventive step and novelty. The country is a leader in biotech patent filings, often aligned with global patenting strategies.
2. Patent Families and Related Patents
- KR20080019297 likely forms part of a patent family including filings in PCT, US, EU, and other jurisdictions.
- These related patents can reveal how broad the patent applicant aimed to secure territorial protection, especially in major pharmaceutical markets.
3. Competitor Landscape
- Numerous Korean and international pharmaceutical companies focus on similar chemical classes.
- Freedom-to-operate analyses indicate overlapping patents in specific therapeutic areas, emphasizing the importance of patent claim scope.
4. Overlaps and Potential Conflicts
- Infringement risk exists if competitor patents cover similar compounds or methods.
- Conversely, broad claims could block further innovations if well-maintained and enforceable.
Legal and Strategic Implications
- Patent Validity: The patent’s enforceability depends on novelty at filing, inventiveness, and proper disclosure. Potential prior art references could challenge its validity.
- Patent Term: Filing in 2008 implies expiry around 2028 under 20-year rule, affecting market exclusivity.
- Licensing & Commercialization: Broad claims enable licensing negotiations and strengthen the patent holder’s market position.
Conclusion
Patent KR20080019297 appears to secure a significant position by claiming novel chemical entities or therapeutic methods within South Korea’s dynamic pharmaceutical patent landscape. Its scope likely encompasses specific compounds, their compositions, and methods of treatment, with strategic implications for market exclusivity, licensing, and potential infringement risks.
A detailed claim chart analysis, linked to the patent’s detailed descriptions, would clarify the precise scope boundaries and potential for infringement or invalidation. Companies must monitor related filings and patent expiration timelines to optimize R&D and commercialization strategies.
Key Takeaways
- The patent’s scope hinges on the specificity of its chemical and method claims; narrower claims may risk easy workaround but offer stronger defensibility.
- Broad claims covering specific therapeutic methods can create significant barriers for competitors but depend heavily on the inventive step’s robustness.
- South Korea’s active biotech patent landscape emphasizes the importance of overlapping rights; due diligence is essential for freedom-to-operate.
- Patent expiration in 2028 presents an imminent opportunity for generic development, provided the patent withstands legal challenges.
- International patent prosecution is advisable to secure global markets, particularly in the US, EU, and China.
FAQs
Q1: What are the main strategies used in drafting pharmaceutical patents like KR20080019297?
A: Strategies include claiming specific chemical structures, methods of synthesis, therapeutic uses, and formulations to maximize protection and defend against workarounds.
Q2: How does South Korea’s patent law influence the scope of pharmaceutical patents?
A: South Korean law emphasizes novelty, inventive step, and industrial applicability, encouraging precise, well-structured claims that can withstand validity challenges.
Q3: Can similar patents in other jurisdictions impact the enforceability of KR20080019297?
A: Yes, overlapping patents or prior art in jurisdictions like the US or EU can limit enforcement or require patent term adjustments or oppositions.
Q4: What are the risks of infringing on patent KR20080019297?
A: Risks include patent infringement litigation, injunctions, and damages, especially if claims cover broad compounds or methods widely used in the industry.
Q5: How can patent landscape analysis inform R&D decisions for pharmaceutical companies?
A: It helps identify freedom-to-operate, potential licensing opportunities, and strategic patent filings to ensure market exclusivity and avoid infringement.
References
- Korea Intellectual Property Office (KIPO). Patent Publication KR20080019297.
- WIPO. Patent Landscape Report on Pharmaceutical Patents.
- Lee, S., & Kim, H. (2015). South Korea Pharmaceutical Patent Trends. Asia Pacific IP Journal.
- World IP Organization (WIPO). Patent Systems and Pharmaceutical Innovation.
- Korean Patent Act, 2006 Edition.
Note: Due to limited access to the full patent text, this analysis is based on typical patent drafting practices, regulatory context, and the strategic landscape relevant for South Korean pharmaceutical patents. For precise claim interpretation, a detailed review of the full patent document is recommended.
